Zynerba Pharmaceuticals, Inc. - stock earnings
Stock symbol ZYNE is outdated, potentially delisted? Maybe it is available on other exchange?
ZYNE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -8.0 million USD | ? USD |
| 2022Q3 | -8.7 million USD | ? USD |
| 2022Q2 | -9.9 million USD | ? USD |
| 2022Q1 | -8.5 million USD | ? USD |
| 2021Q4 | -8.8 million USD | ? USD |
| 2021Q3 | -10.6 million USD | ? USD |
| 2021Q2 | -10.0 million USD | ? USD |
| 2021Q1 | -8.0 million USD | ? USD |
| 2020Q4 | -9.6 million USD | ? USD |
| 2020Q3 | -9.0 million USD | ? USD |
| 2020Q2 | -20.3 million USD | ? USD |
ZYNE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -35.0 million USD | ? USD |
| 2021 | -37.3 million USD | ? USD |
| 2020 | -51.3 million USD | ? USD |
| 2019 | -32.9 million USD | ? USD |
| 2018 | -39.9 million USD | 86000 USD |
| 2017 | -32.0 million USD | ? USD |
ZYNE
Price: $1.30
52 week price:
Earnings Per Share: -0.57 USD
P/E Ratio: -1.83
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 250632
Ebitda: -8.5 millionMarket Capitalization: 19.8 million